NSAID Safety and Efficacy Guidelines

Introduction to NSAID Selection

The American College of Gastroenterology recommends ibuprofen 400-1200 mg/day as the preferred first-line NSAID for simple analgesia without significant inflammation, due to its high analgesic-to-anti-inflammatory ratio, making it less ulcerogenic than other NSAIDs 1, 2
The American Heart Association suggests that ibuprofen has favorable gastrointestinal safety compared to other NSAIDs at low analgesic doses 1, 2
The American College of Rheumatology notes that ibuprofen achieves effective analgesia at doses with minimal anti-inflammatory activity, contributing to its safety advantage 1, 2

For acute, non-inflammatory pain, the American Academy of Family Physicians recommends ibuprofen 400-1200 mg/day as the preferred first-line NSAID 1, 2
The American Gastroenterological Association states that at these low analgesic doses, ibuprofen has favorable gastrointestinal safety compared to other NSAIDs 1, 2
The American College of Cardiology notes that this safety advantage exists because ibuprofen achieves effective analgesia at doses with minimal anti-inflammatory activity 1, 2

For low GI risk patients, the American College of Gastroenterology recommends ibuprofen 400-1200 mg/day for short-term use 1, 2
The American Gastroenterological Association suggests that no gastroprotection is needed for low GI risk patients 3
For moderate GI risk patients, the American College of Gastroenterology recommends non-selective NSAID plus PPI, or celecoxib alone 3
The American Heart Association notes that adding low-dose aspirin to any NSAID increases GI complication risk 2- to 5-fold and negates much of the COX-2 inhibitor's safety advantage 3, 4, 5

The American Heart Association states that all selective COX-2 inhibitors carry increased cardiovascular risk (myocardial infarction, stroke, heart failure, hypertension) 4
The American College of Cardiology recommends naproxen or celecoxib for patients with high cardiovascular risk requiring anti-inflammatory therapy 4
The American College of Cardiology notes that ibuprofen interferes with aspirin's antiplatelet effect: patients on low-dose aspirin should take ibuprofen at least 30 minutes after aspirin or at least 8 hours before aspirin 4

The National Kidney Foundation recommends monitoring blood pressure, BUN, creatinine every 3 months during chronic NSAID therapy 1
The American College of Nephrology suggests avoiding NSAIDs entirely in severe chronic kidney disease 1

The American Geriatrics Society recommends using the lowest effective dose for the shortest duration in elderly patients 6
The American Geriatrics Society suggests that regular acetaminophen (up to 4g/day unless liver disease present) is safer than NSAIDs for musculoskeletal pain 6, 7
The American College of Cardiology notes that always co-prescribing PPI if NSAID cannot be avoided is recommended for elderly patients 6

The American College of Gastroenterology recommends baseline assessment: blood pressure, renal function (BUN, creatinine), liver function, CBC, screen for unexplained iron-deficiency anemia 1
The American Gastroenterological Association suggests monitoring every 3 months: blood pressure, BUN, creatinine, liver function studies, CBC, fecal occult blood 1
The American College of Gastroenterology recommends discontinuing NSAID therapy if BUN or creatinine doubles, hypertension develops/worsens, or liver enzymes increase >3x upper limit of normal 1